CLINICAL OBSERVATIONS WITH 1,6-BIS(β-CHLOROETHYLAMINO)-1,6-DEOXY-D-MANNITOL DIHYDROCHLORIDE (BCM) IN MALIGNANT DISEASES

This publication has 16 references indexed in Scilit:

• Clinical Trials of p-(Di-2-chloroethylamine)-phenylbutyric Acid (CB 1348) in Malignant Lymphoma
  BMJ, 1955
• STUDIES ON THE ANTI-TUMOUR ACTIVITY OF p-DI-(2-CHLOROETHYL) AMINOPHENYLALANINE (SARCOLYSINE)
  The Lancet, 1955
• Möglichkeiten und Grenzen der Therapie des Krebses - vom Standpunkt der experimentellen Forschung¹
  Deutsche Medizinische Wochenschrift (1946), 1954
• Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalanines
  Journal of the Chemical Society, 1954
• 486. Aryl-2-halogenoalkylamines. Part XII. Some carboxylic derivatives of NN-di-2-chloroethylaniline
  Journal of the Chemical Society, 1953
• Experimental Studies on Chemotherapy of Malignant Growth Employing Yoshida Sarcoma Animals
  Proceedings of the Japan Academy, 1951
• A TRIAL OF $beta;-NAPHTHYLDI-2-CHLOROETHYLAMINE (R48) IN LEUKqMIA, HODGKIN'S DISEASE, AND ALLIED DISEASES
  The Lancet, 1950
• The growth-inhibitory and carcinogenic properties of 4-aminostilbene and derivatives
  Philosophical Transactions of the Royal Society of London. Series A, Mathematical and Physical Sciences, 1948
• NITROGEN MUSTARDS IN THE TREATMENT OF NEOPLASTIC DISEASE
  JAMA, 1946
• The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides
  Science, 1946